04 Feb 2019
Medical product alert: falsified rabies vaccine - PhilippinesA report of falsified rabies vaccine circulating in the Philippines
On 30 January 2019, the World Health Organization (WHO) issued a Medical Product Alert concerning falsified Verorab® rabies vaccine circulating in the Philippines. The manufacturer of the authentic Verorab® product has confirmed that they did not manufacture the falsified vaccines. WHO has not received reports of adverse reactions to the falsified product at the time of this report .
Advice for travellers
Authentic rabies vaccine is used to protect those at risk of exposure to rabies (pre-exposure), or to prevent rabies developing following the bite of an animal suspected of having the disease (post- exposure prophylaxis).
Further advice on the worldwide risk of rabies, including the action you should take if bitten, licked or scratched by an animal in a country where rabies is known or presumed to occur, is available from NaTHNaC; Worldwide risk of rabies.
If you recently received a course vaccine in the Philippines after an exposure or for other reasons, you should contact your doctor or a local travel clinic for advice.
Advice for health professionals
This notice applies to the circulation of a falsified product in the Philippines only.
Health professionals with concerns about a traveller who has received this falsified product can call Public Health England: Rabies and Immunoglobulin Service.
The Sanofi Pasteur product Verorab® distributed in the United Kingdom is used with the approval of the Medicines and Healthcare products Regulatory Agency (MHRA).